课题基金 / 基金详情

Role of the GABA transporter, GAT-3, in regulating network excitability in the hippocampus

Role of the GABA transporter, GAT-3, in regulating network excitability in the hippocampus
GABA 转运蛋白 GAT-3 在调节海马网络兴奋性中的作用
批准号:
MR/P025641/1
负责人:
Matthew Walker
金额:
$60.73万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --

项目摘要

项目成果

Matthew Walker的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The hippocampus is a part of the brain that plays a key role in memory and learning. Damage to or dysfunction of the hippocampus is important for the symptoms of a number neurological diseases including Alzheimer's disease and epilepsy. Indeed, damage to the hippocampus from prolonged convulsions in childhood is the commonest cause of drug-resistant epilepsy.In order for the hippocampus to operate normally, there is a fine balance between excitation mediated by the neurotransmitter glutamate, and inhibition mediated by the neurotransmitter GABA. Understanding how these two processes work can help understand the manifestations of neurological disease and how to treat them.Throughout the brain there are nerve cells and glia. Nerve cells communicate with one another and are crucial for brain activity. Glia were once considered "the glue" of the brain and to play purely a supportive role. However, one of the major recent advances in neuroscience is the realisation that glia also play a critical role in brain activity and can also "communicate" to one another and to neurons.Glia can regulate GABA in the hippocampus by mean of a GABA transporter termed GAT3, but also we have recently discovered that activation of GAT3 can result in the release of other chemicals that modify hippocampal function. This research asks how do these different roles of GAT3 complement one another and how does GAT3 control inhibition in the hippocampus. In addition, we will be asking whether modifying GAT3 activity can be used to treat epilepsy.Addressing these questions is critical as GAT3 is a druggable target that could be used to treat a range of neurological and neurodegenerative conditions from epilepsy to Alzheimer's disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/epi.13965
发表时间: 2018-01
期刊: Epilepsia
影响因子: 5.6
作者: [Klein P, Dingledine R, Aronica E, Bernard C, Blümcke I, Boison D, Brodie MJ, Brooks-Kayal AR, Engel J Jr, Forcelli PA, Hirsch LJ, Kaminski RM, Klitgaard H, Kobow K, Lowenstein DH, Pearl PL, Pitkänen A, Puhakka N, Rogawski MA, Schmidt D, Sillanpää M, Sloviter RS, Steinhäuser C, Vezzani A, Walker MC, Löscher W]
通讯作者: Löscher W
Replacing valproate with a safer, broad-spectrum drug for epilepsy treatment
  • 批准号:
    MR/Y019334/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $348.51万
  • 财政年份:
    2024
  • 负责人:
    Matthew Walker
  • 依托单位:
Collaborative Research: Dwarf Galaxies Over Cosmic Time
  • 批准号:
    2206046
  • 项目类别:
    Standard Grant
  • 资助金额:
    $35.7万
  • 财政年份:
    2022
  • 负责人:
    Matthew Walker
  • 依托单位:
Collaborative Research: Finding the Double Sunsets - Stellar Multiplicity Across the Milky Way Halo
  • 批准号:
    1909584
  • 项目类别:
    Standard Grant
  • 资助金额:
    $54.9万
  • 财政年份:
    2019
  • 负责人:
    Matthew Walker
  • 依托单位:
Collaborative Research: Dark Matter and Substructure in the Galactic Halo with Gaia and Multi-Object Spectroscopy
  • 批准号:
    1813881
  • 项目类别:
    Standard Grant
  • 资助金额:
    $58.6万
  • 财政年份:
    2018
  • 负责人:
    Matthew Walker
  • 依托单位:
国内基金
海外基金
脑胶质母细胞瘤中SLC1A3⁺小胶质细胞通过Glu-GABA代谢失衡诱导T细胞耗竭的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    崔舒
  • 依托单位:
基于GABA能神经环路探讨乌藤疏肝丸重塑神经兴奋-抑制平衡的抗抑郁机制
从肝失疏泄探讨肝脏代谢物介导IL-6/STAT3通路调控GABA能系统对睡眠节律影响的机制及逍遥散的干预作用
背根神经节GABA重摄取改变在神经痛中的作用及其机制研究
  • 批准号:
    JCZRLH202600149
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: